Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Roquefort Thera Share News (ROQ)
ROQ Share
Price
ROQ Share
News
ROQ Share
Chat
ROQ Share
Trades6
ROQ
Live RNS
ROQ Share
Charts
ROQ Broker
Ratings
ROQ Directors
Deals
ROQ Financial
Diary
ROQ
Fundamentals
ROQ Short
Positions
ROQ
Media
ROQ Company
Research
ROQ Company
Timeline
- There is currently no data for ROQ
Roquefort Thera News
EARNINGS: Kendrick Resources loss narrows; Emmerson CFO to depart
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News:
Roquefort Therapeutics says MK cell therapy patent approved in Japan
(Alliance News) - Roquefort Therapeutics PLC on Monday announced its patent for mesodermal killer, or MK, cell therapy has been approved by the Japan ...
TRADING UPDATES: Windward wins deal; Kodal progresses at Bougouni
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
EARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters Germany
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...
IN BRIEF: Roquefort cancels fundraise after "unusual" stock movements
Roquefort Therapeutics PLC - London-based biotechnology company - Says it has opted against a fundraise following "unusual share price movements". The...
Roquefort celebrates "significant milestones" in cancer research
(Alliance News) - Roquefort Therapeutics PLC on Monday reported progress in cancer research under two of its medicine development programmes.
IN BRIEF: Roquefort hails further MK studies, licence talks continue
Roquefort Therapeutics PLC - London-based biotechnology company, focused on developing medicines for hard-to-treat cancers - Says it has continued stu...
Follow the stocks
